DAN Liqin, ZHANG Zhonglin, LUO Zhigang. Value of serum insulin-like growth factor-1 levels in diagnosis and treatment of primary hyperthyroidism[J]. Journal of Clinical Medicine in Practice, 2024, 28(24): 73-76. DOI: 10.7619/jcmp.20243907
Citation: DAN Liqin, ZHANG Zhonglin, LUO Zhigang. Value of serum insulin-like growth factor-1 levels in diagnosis and treatment of primary hyperthyroidism[J]. Journal of Clinical Medicine in Practice, 2024, 28(24): 73-76. DOI: 10.7619/jcmp.20243907

Value of serum insulin-like growth factor-1 levels in diagnosis and treatment of primary hyperthyroidism

More Information
  • Received Date: August 29, 2024
  • Revised Date: October 29, 2024
  • Objective 

    To explore the value of serum insulin-like growth factor-1 (IGF-1) levels in diagnosis and treatment of primary hyperthyroidism.

    Methods 

    150 patients with primary hyperthyroidism (hyperthyroidism group) and 85 patients with hypothyroidism (hypothyroidism group) were selected as study subjects. During the same period, 60 healthy individuals were selected as control group. The levels of serum IGF-1, thyroid peroxidase antibody (TPOAb), thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), triiodothyronine (T3) and total thyroxine (T4) were measured in the three groups. The serum visfatin levels in the three groups were detected using an enzyme-linked immunosorbent assay. Multifactor Logistic regression analysis was used to screen for risk factors of primary hyperthyroidism.

    Results 

    The levels of IGF-1, FT3, FT4, T3 and T4 in the hyperthyroidism group were significantly higher than those in the hypothyroidism and control groups, while TSH levels were significantly lower (P < 0.05). TPOAb and visfatin levels in the hyperthyroidism group were significantly higher than those in the control group, but significantly lower than those in the hypothyroidism group (P < 0.05). The serum IGF-1 levels in patients with primary hyperthyroidism before and after 3 months of treatment were (60.11±7.23) and (30.23± 3.22) μg/L, respectively, showing a statistically significant difference (t=8.436, P < 0.001). Serum FT3, FT4, T3, T4, TPOAb, IGF-1 and visfatin levels increased and serum TSH levels decreased as risk factors for primary hyperthyroidism (P < 0.05).

    Conclusion 

    The level of serum IGF-1 is closely related to thyroid function and may serve as an important reference indicator for the diagnosis and monitoring of the efficacy of primary hyperthyroidism treatment.

  • [1]
    LEE S Y, PEARCE E N. Hyperthyroidism: a review[J]. JAMA, 2023, 330(15): 1472-1483. doi: 10.1001/jama.2023.19052
    [2]
    杨悦漪, 林霞, 王丽兵. 25-羟基维生素D、人β防御素-2及胰岛素样生长因子1水平与痤疮患者疾病严重程度的关系[J]. 实用临床医药杂志, 2024, 28(16): 60-64. doi: 10.7619/jcmp.20233195
    [3]
    孟利军, 郭晓鹤, 董戴源, 等. 沙利度胺联合英夫利西治疗难治性炎症性肠病效果及对胰岛素样生长因子-1、转化生长因子-β1的影响[J]. 实用临床医药杂志, 2024, 28(1): 68-72, 77. doi: 10.7619/jcmp.20230274
    [4]
    赵春慧, 宋光耀, 魏立民. 甲状腺相关疾病中IGF-1及其受体的表达及意义[J]. 医学综述, 2015(3): 412-414.
    [5]
    MAHZARI M M, ALANAZI M M, ALABDULKAREEM Y M, et al. Efficacy of anti-thyroid medications in patients with Graves' disease[J]. BMC Endocr Disord, 2024, 24(1): 180. doi: 10.1186/s12902-024-01707-0
    [6]
    闫园园, 魏剑芬, 李世超, 等. 血清胰岛素样生长因子-1与糖尿病合并甲状腺疾病的相关性[J]. 广东医学, 2019, 40(5): 647-651.
    [7]
    王红梅, 姚韧寰, 赵予韬, 等. 探究甲亢患者情绪及睡眠状况及其与血清学指标的相关性[J]. 标记免疫分析与临床, 2022, 29(1): 19-22.
    [8]
    杨建军, 毛利娜, 杨利, 等. 血清胰岛素样生长因子1与内脂素在甲状腺功能亢进患者中的变化及临床意义[J]. 标记免疫分析与临床, 2019, 26(12): 2096-2100.
    [9]
    朱玉芳, 潘革. GH-IGF-1轴与儿童生长发育[J]. 医学综述, 2008, 14(3): 321-323.
    [10]
    张林渊, 张金波, 陶永明, 等. 生长激素对多囊卵巢综合征患者体外受精-胚胎移植的影响[J]. 实用临床医药杂志, 2023, 27(4): 48-51. doi: 10.7619/jcmp.20222139
    [11]
    孙成芝, 何成邦, 汪发莲. 血清转化生长因子阻、游离脂肪酸与甲亢肝损害患者氧化应激状态的相关性分析[J]. 标记免疫分析与临床, 2018, 25(9): 1364-1367.
    [12]
    刘广钊, 何飞屏, 梁季鸿, 等. 甲状腺功能减退患者血清胰岛素样生长因子-1的变化及其意义[J]. 临床荟萃, 2000, 15(20): 916-918.
    [13]
    罗英. 血清内脂素及脂联素联合检测在甲状腺结节良恶性诊断中的价值[J]. 川北医学院学报, 2020, 35(2): 309-312.
    [14]
    谭丽艳, 杨震宇, 潘佳秋. 甲状腺功能异常患者血清内脂素水平的变化及其与甲状腺激素的关系[J]. 实用医学杂志, 2011, 27(19): 3532-3534.
    [15]
    邢琪, 常文龙, 翟娜. 甲状腺功能亢进症患者血清果糖胺、糖化血红蛋白水平及其与糖代谢指标水平的相关性[J]. 检验医学与临床, 2024, 21(15): 2168-2171.
  • Related Articles

    [1]LI Ruibiao, REN Chengbo, WANG Cong, LI Yaru. Comparison of the efficacy of dosimetric parameters defined by different lung volume methods in predicting radiation pneumonitis in patients with non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(19): 5-8, 13. DOI: 10.7619/jcmp.20221246
    [2]YUAN Meifang, YANG Yi, SUN Mengzhen, WEN Xiaobo, ZHAO Biao. Study on thyroid radiation dose of two intensity-modulated radiotherapy plans after radical mastectomy of left breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(24): 16-19. DOI: 10.7619/jcmp.20213277
    [3]PAN Xiang, YANG Yi, HOU Yu, YUAN Meifang. Dosimetric differences of different radiation modes based on Monaco in postoperative intensity modulated radiotherapy of patients with left breast-conserving surgery for breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 1-5. DOI: 10.7619/jcmp.20200621
    [4]PAN Xiang, LI Ya, ZHU Sijin, YANG Yi. Dosimetry difference between field-in-field intensity modulated radiation therapy and fixed field inversely optimized intensity modulated radiation therapy in whole brain radiotherapy[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 12-16. DOI: 10.7619/jcmp.201919003
    [5]AN Xuehong, CAO Hekui, DUAN Shuhao. Effect of spiral fault fixed field intensity modulated radiation therapy on esophageal cancer in middle segment[J]. Journal of Clinical Medicine in Practice, 2018, (11): 101-103. DOI: 10.7619/jcmp.201811028
    [6]LIU Wanjun, ZHANG Xizhi, LI Jun, HUA Wei, ZHANG Xianwen, CHEN Xuemei. Effects of dose calculation algorithm on dosiology of breast cancer patients with intensity modulated radiation therapy[J]. Journal of Clinical Medicine in Practice, 2016, (15): 28-32. DOI: 10.7619/jcmp.201615008
    [7]SONG Chengxia, WANG Jing. Dosimetric study of volumetric modulated arc therapy and intensity modulated radiation therapy in postoperative radiotherapy of cervical carcinoma[J]. Journal of Clinical Medicine in Practice, 2015, (23): 75-77,81. DOI: 10.7619/jcmp.201523023
    [8]LIU Wanjun, ZHANG Xizhi, LI Jun, ZHANG Xianwen, CHEN Xuemei, GUI Longgang. Dosimetry comparison between cyberknife and gamma knife plan for patients with small tumors of lung[J]. Journal of Clinical Medicine in Practice, 2015, (21): 63-65. DOI: 10.7619/jcmp.201521017
    [9]LI Jinkai, CAO Yuandong, LI Caihong, WANG Peipei, SUN Xinchen. Application of volumetric modulated radiation therapy in the radiotherapy of patients with left breast cancer after breast-conserving surgery[J]. Journal of Clinical Medicine in Practice, 2015, (21): 59-62. DOI: 10.7619/jcmp.201521016
    [10]XU Ming, JUN Liang. Effect comparison between Gamma3 nail and PFNA in the treatment of the elderly patients with unstable intertrochanteric fractures[J]. Journal of Clinical Medicine in Practice, 2014, (9): 101-103. DOI: 10.7619/jcmp.201409030
  • Cited by

    Periodical cited type(4)

    1. 王金会,翟建丽,闫喜凤,裴强,屈自如,赵习德. 清胃降逆方联合雷贝拉唑钠肠溶胶囊治疗肝胃郁热型反流性食管炎的疗效及对G-17、PGⅠ、PGⅡ水平的影响. 中医研究. 2023(02): 26-29 .
    2. 顾丹阳,宫跃敏. 老年慢性萎缩性胃炎患者Hp感染、血清G-17、PG表达水平变化. 湖南师范大学学报(医学版). 2021(06): 124-127 .
    3. 种丽莉. 血清胃泌素17联合胃蛋白酶原检测在萎缩性胃炎诊断中的价值. 河南医学研究. 2020(27): 5146-5148 .
    4. 常晓红. 检测降钙素与血清胃蛋白酶原对在萎缩性胃炎并发幽门螺杆菌感染的诊断价值. 兵团医学. 2019(04): 1-2 .

    Other cited types(0)

Catalog

    Article views (31) PDF downloads (3) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return